Hospital admissions for eating disorders among children and young people in England have increased significantly over the past decade, with figures showing a sixfold rise from 2012 to 2022. While adolescent girls continue to represent the majority of cases, there has been a notable uptick in diagnoses among boys, influenced in part by recent trends emphasizing physical appearance and muscularity.
Despite this surge in eating-disorder hospitalizations, another public health concern persists: high rates of overweight and obesity among youth. Data from the 2024 NHS Health Survey for England indicates that 28% of children aged 13 to 15 and 26% of those between 2 and 15 are classified as overweight or living with obesity. This dual challenge has brought increased attention to the use of weight-loss medications, particularly GLP-1 receptor agonists, which have gained popularity among young people.
These drugs, originally developed for medically recognized obesity, are being prescribed more frequently. However, experts caution against conflating medically necessary treatments with individuals seeking medication for aesthetic reasons, such as emulating ultra-thin celebrities. The broader cultural context encourages quick fixes and outsources personal responsibility for lifestyle habits to pharmaceutical solutions, a trend some worry may hinder the development of sustainable, healthy relationships with food and exercise.
Compounding these difficulties is the pervasive presence of ultra-processed foods in children’s diets. Campaign groups report substantial advertising expenditures by food manufacturers on products linked to excessive sugar and calorie intake, including biscuits, chocolate, crisps, and ice cream. Although the UK government introduced restrictions in January 2026 banning unhealthy food and drink advertisements targeting children online and on television before 9 p.m., recent analysis reveals that only about 1% of these adverts fall under the regulation’s enforcement. Companies have shifted their marketing to less regulated platforms, limiting the policy’s impact. Additionally, regional disparities in childhood obesity remain pronounced, with children in the North East of England more likely to be affected than those in the South East.
Educators and health professionals have expressed concern over the interplay of these factors. Cathy Walker, a long-standing teacher and education consultant, noted the reversal of the body-positivity movement among young people and questioned the ability of weight-loss drugs to address complex issues surrounding youth body image and health. Nevertheless, she observed emerging resistance to extreme thinness ideals within some younger female populations, with growing acceptance of strength and fitness as preferred attributes.
As GLP-1 medications become more common among children and adolescents, discussions around appropriate use continue. Stakeholders emphasize the importance of ensuring these treatments remain accessible to those with clinical needs rather than becoming lifestyle accessories driven by appearance-related pressures. Experts also highlight the need for wider investment in community support and health promotion, especially given the ongoing cost-of-living challenges that make maintaining nutritious diets and physical activity difficult. The balance between medical interventions and addressing systemic factors will likely shape future approaches to tackling obesity and eating disorders in young people across England.